Director Gregory Durant Resigns for Health Reasons; Board Chair Kandarian Takes Audit Committee Lead
JXN sits 29% above its 52-week low of $82.65.
Summary
Gregory T. Durant resigned from Jackson Financial's Board of Directors and his role as Audit Committee Chair due to health reasons, with Board Chair Steven A. Kandarian immediately stepping in to lead the Audit Committee.
Key Events · Executive and Board Changes · JXN
-
Director Resignation
Gregory T. Durant resigned from the Board of Directors effective June 22, 2026, citing health reasons.
-
Audit Committee Leadership Change
Mr. Durant was the chair of the Audit Committee and a member of the Compensation Committee. Steven A. Kandarian, current Board Chair, has been appointed to replace him as Audit Committee Chair.
-
No Disagreement
The company stated that Mr. Durant's resignation was not due to any disagreement with the company.
Analysis · JXN · Finance
Gregory T. Durant, a director and chair of the Audit Committee, resigned for health reasons. While any board departure is notable, the company explicitly stated there was no disagreement. The immediate appointment of Board Chair Steven A. Kandarian to lead the Audit Committee ensures continuity in a critical oversight role.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 29.2% of the 1541 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JXN was trading at $106.44 on NYSE in the Finance sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $82.65 to $123.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.